Role of radiation therapy in the treatment of resectable rectal adenocarcinoma
β Scribed by William M. Mendenhall; W. Robert Rout; D. Scott Lind; Robert A. Zlotecki; Steven N. Hochwald; Scott R. Schell; Edward M. Copeland III
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 108 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The purpose of this study is to review the role of radiation therapy in the treatment of resectable rectal adenocarcinoma. Selection criteria, treatment techniques, and results are discussed. J. Surg. Oncol. 2002;79:107β117. Β© 2002 WileyβLiss, Inc.
π SIMILAR VOLUMES
One hundred and one cases of early and late supraglottic tumors covering a period of 22 years have been evaluated. The early stages, without lymph node metastasis, show a 75% 2-year control and a 50% 5-year survival. T h e local control rate is 75% in those patients treated at a dose equivalent to m
we evaluated the institutional experience of local recurrence and survival in patients with rectal adenocarcinoma treated with pre-operative radiation therapy (PRT) as compared to those treated with radical surgery alone. There were 412 patients, divided into two groups: 259 patients (142 males and
Radiation therapy has assumed an integral role in the treatment of rectal carcinoma. The major role is in the surgical adjuvant setting in which the addition of radiation therapy can decrease the risk of local failure from up to 50% for stages B2 and C, to approximately 20%. The addition of sensitiz